Urbanization, altitude and cardiovascular risk
File(s)1130-5020-1-PB.pdf (950.55 KB)
Published version
Author(s)
Carrillo Larco, Rodrigo
Bernabe-Ortiz, Antonio
Type
Journal Article
Abstract
Background:
There is limited information regarding the variation of the cardiovascular (CV) risk, that combines multiple risk factors in one metric, according to urbanization and altitude.
Objective:
To assess and disentangle the potential association between urbanization and altitude with absolute CV risk using Peruvian nationally-representative surveys.
Methods:
Pooled analysis of Peruvian Demographic Health Surveys (from 2014 to 2020), including subjects aged between 40 and 74 years, was conducted. The outcome of interest was the 10-year predicted absolute CV risk based on the non-laboratory version of the World Health Organization (WHO) and split into <10% and ≥10%. The exposures were urbanization (rural or urban) and altitude (<500 meters above the sea level [m.a.s.l.], between 500 and 2,499 m.a.s.l, between 2,500 and 3,499 m.a.s.l., and ≥3,500 m.a.s.l.). Crude and adjusted Poisson regression models were built to assess the associations of interest, reporting prevalence ratios (PR) and 95% confidence intervals (95% CI).
Results:
Data of 80,409 subjects, mean age 54.3 (SD: 8.8) and 42,640 (54.4%) females were analyzed. Regarding urbanization, 30,722 (25.4%) subjects were from rural areas, and 60.6% lives at <500 m.a.s.l., whereas only 9.3% lives at ≥3500 m.a.s.l. The 10-year predicted absolute CV risk mean was 4.5% (SD: 3.1), and 7.8% had a CV risk ≥10%. In multivariable model, urbanization, mainly rurality (PR=0.89; 95%CI: 0.81–0.97) and altitude (PR=0.82; 95%CI: 0.75–0.90 for those living between 2,500–3,490 m.a.s.l. and PR=0.68; 95%CI: 0.60–0.76 for those living ≥3,500 m.a.s.l) were factors independently associated with CV risk. Urbanization was an effect modifier of the association between altitude and CV risk with a greater effect in urban settings.
Conclusion
Urbanization, specifically rurality, and high-altitude, mainly ≥2,500 m.a.s.l., were factors independently associated with lower predicted CV risk.
There is limited information regarding the variation of the cardiovascular (CV) risk, that combines multiple risk factors in one metric, according to urbanization and altitude.
Objective:
To assess and disentangle the potential association between urbanization and altitude with absolute CV risk using Peruvian nationally-representative surveys.
Methods:
Pooled analysis of Peruvian Demographic Health Surveys (from 2014 to 2020), including subjects aged between 40 and 74 years, was conducted. The outcome of interest was the 10-year predicted absolute CV risk based on the non-laboratory version of the World Health Organization (WHO) and split into <10% and ≥10%. The exposures were urbanization (rural or urban) and altitude (<500 meters above the sea level [m.a.s.l.], between 500 and 2,499 m.a.s.l, between 2,500 and 3,499 m.a.s.l., and ≥3,500 m.a.s.l.). Crude and adjusted Poisson regression models were built to assess the associations of interest, reporting prevalence ratios (PR) and 95% confidence intervals (95% CI).
Results:
Data of 80,409 subjects, mean age 54.3 (SD: 8.8) and 42,640 (54.4%) females were analyzed. Regarding urbanization, 30,722 (25.4%) subjects were from rural areas, and 60.6% lives at <500 m.a.s.l., whereas only 9.3% lives at ≥3500 m.a.s.l. The 10-year predicted absolute CV risk mean was 4.5% (SD: 3.1), and 7.8% had a CV risk ≥10%. In multivariable model, urbanization, mainly rurality (PR=0.89; 95%CI: 0.81–0.97) and altitude (PR=0.82; 95%CI: 0.75–0.90 for those living between 2,500–3,490 m.a.s.l. and PR=0.68; 95%CI: 0.60–0.76 for those living ≥3,500 m.a.s.l) were factors independently associated with CV risk. Urbanization was an effect modifier of the association between altitude and CV risk with a greater effect in urban settings.
Conclusion
Urbanization, specifically rurality, and high-altitude, mainly ≥2,500 m.a.s.l., were factors independently associated with lower predicted CV risk.
Date Issued
2022-06-21
Date Acceptance
2022-05-27
Citation
Global Heart, 2022, 17 (1)
ISSN
2211-8179
Publisher
Ubiquity Press
Journal / Book Title
Global Heart
Volume
17
Issue
1
Copyright Statement
© 2022 The Author(s). This is an
open-access article distributed
under the terms of the Creative
Commons Attribution 4.0
International License (CC-BY
4.0), which permits unrestricted
use, distribution, and
reproduction in any medium,
provided the original author
and source are credited. See
http://creativecommons.org/
licenses/by/4.0/.
open-access article distributed
under the terms of the Creative
Commons Attribution 4.0
International License (CC-BY
4.0), which permits unrestricted
use, distribution, and
reproduction in any medium,
provided the original author
and source are credited. See
http://creativecommons.org/
licenses/by/4.0/.
License URL
Sponsor
Wellcome Trust
Grant Number
214185/Z/18/Z
Publication Status
Published
Article Number
ARTN 42